NEXT Financial Group, Inc - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 216 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.35 and the average weighting 0.0%.

Quarter-by-quarter ownership
NEXT Financial Group, Inc ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$2,000
-50.0%
330
-39.8%
0.00%
Q3 2021$4,000
-20.0%
5480.0%0.00%
Q2 2021$5,0000.0%5480.0%0.00%
Q1 2021$5,0000.0%5480.0%0.00%
Q4 2020$5,000
-16.7%
5480.0%0.00%
-100.0%
Q3 2020$6,000
+500.0%
548
+246.8%
0.00%
Q1 2020$1,000
-99.9%
158
+45.0%
0.00%
Q2 2017$1,000,0000.0%1090.0%0.00%
Q1 2017$1,000,0000.0%1090.0%0.00%
Q4 2016$1,000,000
+99900.0%
1090.0%0.00%
Q3 2016$1,0001090.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
STONERIDGE INVESTMENT PARTNERS LLC 521,775$4,258,0000.53%
Round Table Services, LLC 73,500$600,0000.47%
Cheyne Capital Management (UK) LLP 160,000$1,305,0000.42%
SABBY MANAGEMENT, LLC 906,000$7,393,0000.27%
Bellevue Asset Management AG 200,000$1,632,0000.23%
GLOBEFLEX CAPITAL L P 122,000$996,0000.18%
WASATCH ADVISORS LP 1,959,114$15,986,0000.17%
EMERALD ADVISERS, LLC 288,486$2,354,0000.11%
Rotella Capital Management, Inc. 13,840$113,0000.09%
Catalyst Capital Advisors LLC 65,000$530,0000.06%
View complete list of INOVIO PHARMACEUTICALS INC shareholders